These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28293303)

  • 21. The Effect of Coronavirus Disease-19 Pandemic Lockdown and the Overlapping Ramadan Fasting Period on Glucose Control in Insulin-Treated Patients With Diabetes: A Flash Glucose Monitoring Study.
    Helal R; Ashraf T; Majeed M; Lessan N
    Front Nutr; 2022; 9():843938. PubMed ID: 35433783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose variability indices predict the episodes of nocturnal hypoglycemia in elderly type 2 diabetic patients treated with insulin.
    Klimontov VV; Myakina NE
    Diabetes Metab Syndr; 2017; 11(2):119-124. PubMed ID: 27569727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose Fluctuations during Gestation: An Additional Tool for Monitoring Pregnancy Complicated by Diabetes.
    Dalfrà MG; Chilelli NC; Di Cianni G; Mello G; Lencioni C; Biagioni S; Scalese M; Sartore G; Lapolla A
    Int J Endocrinol; 2013; 2013():279021. PubMed ID: 24319455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of glycemic lability and severity of hypoglycemia in Korean patients with type 1 diabetes.
    Kim SK; Kwon SB; Yoon KH; Ahn KJ; Kang JG; Jung HS; Kang ES; Kim JH; Kim KW
    Endocr J; 2011; 58(6):433-40. PubMed ID: 21505268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Factors of Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Study Based on Continuous Glucose Monitoring.
    Torimoto K; Okada Y; Hajime M; Tanaka K; Tanaka Y
    Diabetes Technol Ther; 2018 Sep; 20(9):603-612. PubMed ID: 30070933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-day continuous glucose monitoring for rapid assessment of hypoglycemic events and glycemic variability in type 1 diabetic patients.
    Kim SK; Suh S; Kim MY; Chung HS; Hur KY; Kim SW; Chung JH; Lee MS; Min YK; Kim KW; Kim JH
    Endocr J; 2011; 58(7):535-41. PubMed ID: 21532214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factory-calibrated continuous glucose monitoring and capillary blood glucose monitoring in a case with insulinoma: usefulness and possible pitfall under chronic hyperinsulinemic hypoglycemia.
    Suminaga K; Murakami T; Yabe D; Sone M; Sugawa T; Masui T; Uza N; Yoshizawa A; Ogura M; Yasoda A; Inagaki N
    Endocr J; 2020 Mar; 67(3):361-366. PubMed ID: 31761874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel analytical method for assessing glucose variability: using CGMS in type 1 diabetes mellitus.
    McCall AL; Cox DJ; Crean J; Gloster M; Kovatchev BP
    Diabetes Technol Ther; 2006 Dec; 8(6):644-53. PubMed ID: 17109596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of the Continuous Glucose Monitoring System (CGMS) in the 72-hour fast test in two patients with hypoglycemia.
    Wang X
    Diabetes Technol Ther; 2004 Dec; 6(6):883-6. PubMed ID: 15684643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel approach to continuous glucose analysis utilizing glycemic variation.
    McDonnell CM; Donath SM; Vidmar SI; Werther GA; Cameron FJ
    Diabetes Technol Ther; 2005 Apr; 7(2):253-63. PubMed ID: 15857227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of glucose variability in subjects with prediabetes.
    Chakarova N; Dimova R; Grozeva G; Tankova T
    Diabetes Res Clin Pract; 2019 May; 151():56-64. PubMed ID: 30935927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Effect of Everolimus on Refractory Hypoglycemia in a Patient with Inoperable Metastatic Insulinoma Evaluated by Continuous Glucose Monitoring.
    Yanagiya S; Cho KY; Nakamura A; Nomoto H; Kawamoto Y; Kawakubo K; Komatsu Y; Mitsuhashi T; Miyoshi H; Atsumi T
    Intern Med; 2018 Sep; 57(17):2527-2531. PubMed ID: 29877259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1,5-anhydroglucitol as a useful marker for assessing short-term glycemic excursions in type 1 diabetes.
    Seok H; Huh JH; Kim HM; Lee BW; Kang ES; Lee HC; Cha BS
    Diabetes Metab J; 2015 Apr; 39(2):164-70. PubMed ID: 25922811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial.
    Tanenberg R; Bode B; Lane W; Levetan C; Mestman J; Harmel AP; Tobian J; Gross T; Mastrototaro J
    Mayo Clin Proc; 2004 Dec; 79(12):1521-6. PubMed ID: 15595336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose excursions and glycaemic control during Ramadan fasting in diabetic patients: insights from continuous glucose monitoring (CGM).
    Lessan N; Hannoun Z; Hasan H; Barakat MT
    Diabetes Metab; 2015 Feb; 41(1):28-36. PubMed ID: 25497966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation.
    Ryan EA; Shandro T; Green K; Paty BW; Senior PA; Bigam D; Shapiro AM; Vantyghem MC
    Diabetes; 2004 Apr; 53(4):955-62. PubMed ID: 15047610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Four-Point Preprandial Self-Monitoring of Blood Glucose for the Assessment of Glycemic Control and Variability in Patients with Type 2 Diabetes Treated with Insulin and Vildagliptin.
    Tura A; Farngren J; Schweizer A; Foley JE; Pacini G; Ahrén B
    Int J Endocrinol; 2015; 2015():484231. PubMed ID: 26587020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CGM for insulinoma screening: a prospective and observational case-control study.
    Ma J; Huang X; Zhao J; Lu J; Lu W; Bao Y; Zhou J; Han J
    Endocr Relat Cancer; 2021 May; 28(5):291-300. PubMed ID: 33729991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Metabolic/glycemic control accuracy, effect and complications of the continuous glucose monitoring system in diabetic patients].
    Maia FF; Araújo LR
    Rev Assoc Med Bras (1992); 2006; 52(6):395-400. PubMed ID: 17242774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.